Daytime Light Exposure for Insomnia in Critically Ill Children
Trial Summary
What is the purpose of this trial?
A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.
Do I need to stop my child's current medications for the trial?
The trial information does not specify whether your child needs to stop taking current medications. It's best to discuss this with the trial coordinators.
What data supports the effectiveness of the treatment Daytime light exposure and Daytime restricted feeding for insomnia in critically ill children?
Research suggests that light therapy can help maintain and reset the body's internal clock, which may improve sleep patterns. Additionally, strategies to improve sleep in intensive care settings have shown benefits in adults, such as reduced delirium and better recovery, which could be relevant for children as well.12345
Is daytime light exposure safe for humans?
Daytime light exposure is generally considered safe for humans and has been used to help maintain and resynchronize circadian rhythms (the body's internal clock) in various settings, including intensive care units. However, more research with clearly defined interventions and objective outcome measures is needed to fully understand its effects.12456
How does the treatment of daytime light exposure and restricted feeding differ from other treatments for insomnia in critically ill children?
This treatment is unique because it focuses on using natural light exposure during the day and restricting feeding to daytime hours to help regulate the child's internal clock (circadian rhythm), which is often disrupted in the intensive care environment. Unlike traditional treatments that may rely on medications, this approach aims to restore natural sleep patterns through environmental and behavioral changes.23457
Eligibility Criteria
This trial is for critically ill children aged 3 to 6 who are admitted to the Pediatric Intensive Care Unit (PICU) and expected to stay at least 24-48 hours. A parent who speaks English must be present. It's not specified who can't join, but typically those with conditions affecting sleep or circadian rhythms might be excluded.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Standard of Care
Participants receive routine critical care while feasibility of sleep and circadian rhythm measurement is assessed using actigraphy and salivary melatonin samples
Daytime Light Exposure
Participants receive timed exposure to a light box of 10,000 lux for PICU days #2, 3, and 4 while undergoing sleep monitoring and salivary melatonin sampling
Daytime Restricted Feeding
Participants have all nutrition restricted to daytime hours for PICU days #2, 3, and 4 while undergoing sleep monitoring and salivary melatonin sampling
Follow-up
Participants are monitored for safety and effectiveness after interventions
Treatment Details
Interventions
- Daytime light exposure
- Daytime restricted feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor